1. Home
  2. PXS vs PASG Comparison

PXS vs PASG Comparison

Compare PXS & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pyxis Tankers Inc.

PXS

Pyxis Tankers Inc.

HOLD

Current Price

$3.06

Market Cap

29.7M

ML Signal

HOLD

PASG

Passage Bio Inc.

HOLD

Current Price

$8.24

Market Cap

27.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PXS
PASG
Founded
2015
2017
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.7M
27.6M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PXS
PASG
Price
$3.06
$8.24
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$34.50
AVG Volume (30 Days)
25.4K
42.1K
Earning Date
11-20-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,491,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$26.08
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.47
$5.12
52 Week High
$4.40
$26.60

Technical Indicators

Market Signals
Indicator
PXS
PASG
Relative Strength Index (RSI) 68.80 53.47
Support Level $2.63 $7.13
Resistance Level $3.13 $9.20
Average True Range (ATR) 0.10 1.02
MACD 0.05 0.08
Stochastic Oscillator 85.94 59.72

Price Performance

Historical Comparison
PXS
PASG

About PXS Pyxis Tankers Inc.

Pyxis Tankers Inc is an international maritime transportation company focused on mid-sized eco-vessels for the product tanker and dry-bulk sectors. It owns a fleet that comprises double-hull product tankers employed under a mix of short- and medium-term time charters and spot charters. The fleet owned by the company includes Konkar Ormi, Pyxis Lamda, Konkar Venture, Pyxis Karteria, and others. Each of the vessels in the fleet is capable of transporting refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel, fuel oil, and other liquid bulk items, such as vegetable oils and organic chemicals. The company operates under two reportable segments, Tanker Vessels, which derive maximum revenue, and Dry-bulk Vessels.

About PASG Passage Bio Inc.

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.

Share on Social Networks: